Viewing Study NCT05694728


Ignite Creation Date: 2025-12-26 @ 11:11 AM
Ignite Modification Date: 2025-12-29 @ 8:37 AM
Study NCT ID: NCT05694728
Status: COMPLETED
Last Update Posted: 2023-01-23
First Post: 2022-12-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine
Sponsor: Beijing Health Guard Biotechnology, Inc
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-05-23
Start Date Type: ACTUAL
Primary Completion Date: 2020-12-11
Primary Completion Date Type: ACTUAL
Completion Date: 2021-01-27
Completion Date Type: ACTUAL
First Submit Date: 2022-12-12
First Submit QC Date: None
Study First Post Date: 2023-01-23
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-01-12
Last Update Post Date: 2023-01-23
Last Update Post Date Type: ACTUAL